(Q34206798)

English

Tri-Modality therapy with I-125 brachytherapy, external beam radiation therapy, and short- or long-term hormone therapy for high-risk localized prostate cancer (TRIP): study protocol for a phase III, multicenter, randomized, controlled trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Tri-Modality therapy with I-125 brachytherapy, external beam radiation therapy, and short- or long-term hormone therapy for high-risk localized prostate cancer (TRIP): study protocol for a phase III, multicenter, randomized, controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

phase III clinical trial

0 references

multicenter clinical trial

0 references

Adaptive radiation therapy

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Hiroyuki Konaka

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Shin Egawa

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Shiro Saito

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Atsunori Yorozu

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Hiroyuki Takahashi

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Keiko Miyakoda

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Masanori Fukushima

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Takushi Dokiya

8

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Hidetoshi Yamanaka

9

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Nelson N Stone

10

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Mikio Namiki

11

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

0 references

publication date

22 March 2012

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

110

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

https://scigraph.springernature.com/pub.10.1186/1471-2407-12-110

0 references

AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: report of Task Group 137.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3350387

5 July 2018

Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3350387

5 July 2018

Validation of Partin tables and development of a preoperative nomogram for Japanese patients with clinically localized prostate cancer using 2005 International Society of Urological Pathology consensus on Gleason grading: data from the Clinicopathol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3350387

5 July 2018

Brachytherapy with permanent seed implantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3350387

5 July 2018

Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3350387

5 July 2018

Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3350387

5 July 2018

Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3350387

5 July 2018

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3350387

5 July 2018

The changing face of low-risk prostate cancer: trends in clinical presentation and primary management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3350387

5 July 2018

Multimodality radiotherapy and androgen ablation in the treatment of clinically localized prostate cancer: early results in high risk patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3350387

5 July 2018

Treatment of prostate cancer with radiotherapy: should the entire seminal vesicles be included in the clinical target volume?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3350387

5 July 2018

Role of hormonal therapy in the management of intermediate- to high-risk prostate cancer treated with permanent radioactive seed implantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3350387

5 July 2018

Prostate brachytherapy: treatment strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3350387

5 July 2018

American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3350387

5 July 2018

Supraadditive apoptotic response of R3327-G rat prostate tumors to androgen ablation and radiation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3350387

5 July 2018

A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3350387

5 July 2018

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-110

21 January 2018

Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-110

21 January 2018

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-110

21 January 2018

Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-110

21 January 2018

Duration of androgen suppression in the treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-110

21 January 2018

Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-110

21 January 2018

Biologically effective dose values for prostate brachytherapy: effects on PSA failure and posttreatment biopsy results.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-110

21 January 2018

Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-110

21 January 2018

Late genitourinary and gastrointestinal toxicity after magnetic resonance image-guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-110

21 January 2018

The effect of supplemental beam radiation on prostate brachytherapy-related morbidity: morbidity outcomes from two prospective randomized multicenter trials

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-110

21 January 2018

Urinary and rectal complications of contemporary permanent transperineal brachytherapy for prostate carcinoma with or without external beam radiation therapy

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-110

21 January 2018

Flutamide-associated liver toxicity during treatment with total androgen suppression and radiation therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-110

21 January 2018

Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer?: meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-110

21 January 2018

Predicting recurrence after radical prostatectomy for patients with high risk prostate cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3350387

28 October 2018

Influence of Androgen Suppression Therapy for Prostate Cancer on the Frequency and Timing of Fatal Myocardial Infarctions

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-110

21 January 2018

Changing the patterns of failure for high-risk prostate cancer patients by optimizing local control

1 reference

https://pubmed.ncbi.nlm.nih.gov/22439742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

15-Year biochemical relapse free survival in clinical Stage T1-T3 prostate cancer following combined external beam radiotherapy and brachytherapy; Seattle experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/22439742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Androgen deprivation therapy does not impact cause-specific or overall survival in high-risk prostate cancer managed with brachytherapy and supplemental external beam

1 reference

https://pubmed.ncbi.nlm.nih.gov/22439742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term outcomes after treatment with brachytherapy and supplemental conformal radiation for prostate cancer patients having intermediate and high-risk features

1 reference

https://pubmed.ncbi.nlm.nih.gov/22439742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality of life and satisfaction with outcome among prostate-cancer survivors

1 reference

https://pubmed.ncbi.nlm.nih.gov/22439742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Local control following permanent prostate brachytherapy: effect of high biologically effective dose on biopsy results and oncologic outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/22439742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/22439742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HIGH DOSE RADIATION DELIVERED BY INTENSITY MODULATED CONFORMAL RADIOTHERAPY IMPROVES THE OUTCOME OF LOCALIZED PROSTATE CANCER

1 reference

https://pubmed.ncbi.nlm.nih.gov/22439742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22439742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Androgen deprivation and radiation therapy in prostate cancer: the evolving case for combination therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22439742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22439742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update

1 reference

https://pubmed.ncbi.nlm.nih.gov/22439742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progression in and survival of patients with locally advanced prostate cancer (T3) treated with radical prostatectomy as monotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22439742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined external beam radiotherapy and Pd-103 brachytherapy boost improves biochemical failure free survival in patients with clinically localized prostate cancer: results of a matched pair analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22439742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose

1 reference

https://pubmed.ncbi.nlm.nih.gov/22439742

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-12-110

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34206798&oldid=1634997628"